Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Oct 2, 2014
Insider Transaction Report
Form 4
Plattner Jacob j
Senior VP Research
Transactions
- Sale
Common Stock
2014-10-01$24.47/sh−6,875$168,231→ 78,975 total(indirect: See Footnote)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2014.
- [F2]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.